Noninvasive clinical assessment of skin irritation/inflammation

Handbook of Cosmetic Science and Technology, Third Edition

Volumn , Issue , 2009, Pages 481-488

  Robinson, Michael K ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856199724     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (30)

1. Kligman AM. The invisible dermatoses. Arch Dermatol 1991; 127:1375-1382.
2. Kligman AM. Perspectives on bioengineering of the skin. In: Serup J, Jemec GB, eds. Handbook of Noninvasive Methods and The Skin. Boca Raton, Florida: CRC Press, 1995; 3-8.
3. Stotts J. Planning, conduct, and interpretation of human predictive sensitization patch tests. In: Drill VA, Lazar P, eds. Current Concepts in Cutaneous Toxicity. New York, NY: Academic Press, 1980; 41-53.
4. Fregert S. Manual of contact dermatitis. 2nd ed. Chicago: Year Book Medical Publisher, 1981.
5. Robinson MK, Perkins MA, Basketter DA. Application of a 4-h human patch test method for comparative and investigative assessment of skin irritation. Contact Dermat 1998; 38:194-202.
6. Serup J, Jemec GBE. Handbook of noninvasive methods and the skin. Boca Raton: CRC Press, 1995.
7. Gerberick GF, Rheins LA, Ryan CA, et al. Increases in human epidermal DR(+)CD1(+), DR(+)CD1(-) CD36(+), and DR(-)CD3(+) cells in allergic versus irritant patch test responses. J Invest Dermatol 1994; 103:524-529.
8. Arestides RSS, He HZ, Westlake RM, et al. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002; 32:2874-2880.
9. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30:535-546.
10. Ryan CA, Gerberick GF. Cytokine mRNA expression in human epidermis after patch treatment with rhus and sodium lauryl sulfate. Am J Contact Dermatitis 1999; 10:127-135.
11. Hirao T, Aoki H, Yoshida T, et al. Elevation of interleukin 1 receptor antagonist in the stratum corneum of sun-exposed and ultraviolet B- irradiated human skin. J Invest Dermatol 1996; 106:1102-1107.
12. Perkins MA, Farage MA, Wong TK, et al. Development of a noninvasive method for assessing human skin irritation. Fundam Appl Toxicol 1997; 36:365.
13. Perkins MA, Osterhues MA, Robinson MK. Noninvasive method for assessing inflammatory changes in chemically treated human skin. J Invest Dermatol 1999; 112:601.
14. Perkins MA, Osterhues MA, Farage MA, et al. A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation. Skin Res Technol 2001; 7:227-237.
15. Terui T, Hirao T, Sato Y, et al. An increased ratio of interleukin-1 receptor antagonist to interleukin-1 alpha in inflammatory skin diseases. Exp Dermatol 1998; 7:327-334.
16. Hammerberg C, Arend WP, Fisher GJ, et al. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 1992; 90:571-583.
17. Robinson MK, Perkins MA. A strategy for skin irritation testing. Am J Contact Dermat 2002; 13:21-29.
18. Gahring LC, Buckley A, Daynes RA. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 1985; 76:1585-1591.
19. Perkins MA, Cardin CW, Osterhues MA, et al. A non-invasive tape absorption method for recovery of inflammatory mediators to differentiate normal from compromised scalp conditions. Skin Res Technol 2002; 8:187-193.
20. Helm KF, Menz J, Gibson LE, et al. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991; 25:1038-1043.
21. Barton K, Monroy DC, Nava A, et al. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 1997; 104:1868-1874.
22. Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg 2001; 20:199-206.
23. Robinson MK, Schwartz JF, Perkins MA. Application of a novel and noninvasive skin sampling technique for analyzing cytokine-mediated inflammation in rosacea. J Toxicol Cutan Ocul Toxicol 2003; 22:13-22.
24. Perkins MA, Biesbrock AR, Robinson MK, et al. Reapplication of a novel noninvasive method for assessing the relationship of gingival inflammation and bleeding to gingival epithelium cytokine concentrations. Toxicol Sci 1999; 48:53.
25. Perkins MA, Osterhues MA, Vogelpohl S, et al. A clinical skin sampling approach to asses sensory skin irritation. Toxicol Sci 2000; 54:146.
26. Hendrix SW, Miller KH, Youket TE, et al. Optimization of the skin multiple analyte profile bioanalytical method for determination of skin biomarkers from D-Squame” tape samples. Skin Res Technol 2007; 13:330-342.
27. De Jongh CM, Verberk MM, Spiekstra SW, et al. Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin. Skin Res Technol 2007; 13:390-398.
28. Morhenn VB, Chang EY, Rheins LA. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. J Am Acad Dermatol 1999; 41:687-692.
29. Wong R, Tran V, Morhenn V, et al. Use of RT-PCR and DNA microarrays to characterize RNA recovered by non-invasive tape harvesting of normal and inflamed skin. J Invest Dermatol 2004; 123:159-167.
30. Benson NR, Papenfuss J, Wong R, et al. An analysis of select pathogenic messages in lesional and nonlesional psoriatic skin using non-invasive tape harvesting. J Invest Dermatol 2006; 126:2234-2241.